Mar 3, 2020 Corcept also has 14 quarters of earnings growth under its belt, and sales have grown by double-digit percentages for several years. Corcept  Jan 17, 2020 As Nuplazid is the only drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of PDP, it has an exciting market 

Jun 4, 2019 Many of the companies in the biotech sector have had a rough past few weeks with many stocks hitting their lowest levels since January. Apr 8, 2019 However, as with any investment, investing in the biotechnology space can come with risk. With many of these companies being in clinical stages,  Dec 17, 2019 Finfeed runs the ruler over the biotech stocks to watch in 2020. end of 2019 has now been rescheduled by the FDA to early first quarter 2020. Nov 27, 2018 With the Russell 2000 extremely weak right now it's still too early to go long most penny stocks. However, biotech stocks have entered their  Jun 3, 2019 Everything is great right? While the [] The post The Wealthy Elites secretly loading up on Gold. Now is the time to buy Gold mining stocks […]. Small-cap biotech stocks have consistently been one of the best-performing groups of equities for almost 10 straight years. Vertex just might be the best biotech stock on the market right now. The company's three approved drugs -- Kalydeco, Orkambi, and Symdeko -- enjoy a virtual monopoly in treating the underlying

Sep 3, 2019 Right now, PharmaCyte Biotech (PMCB) is putting together the necessary material for its planned clinical trial for inoperable pancreatic cancer, 

Dec 17, 2019 Finfeed runs the ruler over the biotech stocks to watch in 2020. end of 2019 has now been rescheduled by the FDA to early first quarter 2020. Nov 27, 2018 With the Russell 2000 extremely weak right now it's still too early to go long most penny stocks. However, biotech stocks have entered their  Jun 3, 2019 Everything is great right? While the [] The post The Wealthy Elites secretly loading up on Gold. Now is the time to buy Gold mining stocks […]. Small-cap biotech stocks have consistently been one of the best-performing groups of equities for almost 10 straight years. Vertex just might be the best biotech stock on the market right now. The company's three approved drugs -- Kalydeco, Orkambi, and Symdeko -- enjoy a virtual monopoly in treating the underlying Biotech Stocks to Buy: Voyager Therapeutics (VYGR) Voyager Therapeutics (NASDAQ: VYGR) shares are getting a lift off of their 50-week moving average ahead of a possible run to the highs not seen since March, which would be worth a 50%+ gain from here as it emerges from a two-month consolidation range. When it comes to mining, investors look for “safe havens” to hedge against financial crises. As for biotechnology, investors turn toward this area of the market as it tends to see less impact from geopolitical events. Here’s a list of 5 penny stocks to watch right now. Penny Stocks To Watch: Biocept Inc.

When it comes to mining, investors look for “safe havens” to hedge against financial crises. As for biotechnology, investors turn toward this area of the market as it tends to see less impact from geopolitical events. Here’s a list of 5 penny stocks to watch right now. Penny Stocks To Watch: Biocept Inc.

Jun 4, 2019 Many of the companies in the biotech sector have had a rough past few weeks with many stocks hitting their lowest levels since January. Apr 8, 2019 However, as with any investment, investing in the biotechnology space can come with risk. With many of these companies being in clinical stages, 

Dec 17, 2019 Finfeed runs the ruler over the biotech stocks to watch in 2020. end of 2019 has now been rescheduled by the FDA to early first quarter 2020.

Jun 3, 2019 Everything is great right? While the [] The post The Wealthy Elites secretly loading up on Gold. Now is the time to buy Gold mining stocks […]. Small-cap biotech stocks have consistently been one of the best-performing groups of equities for almost 10 straight years. Vertex just might be the best biotech stock on the market right now. The company's three approved drugs -- Kalydeco, Orkambi, and Symdeko -- enjoy a virtual monopoly in treating the underlying

5 days ago At the start of 2020, shares traded around $0.25. Since then, the biotech penny stock has managed to reach highs of $3.40. After consolidating 

Nov 27, 2018 With the Russell 2000 extremely weak right now it's still too early to go long most penny stocks. However, biotech stocks have entered their  Jun 3, 2019 Everything is great right? While the [] The post The Wealthy Elites secretly loading up on Gold. Now is the time to buy Gold mining stocks […]. Small-cap biotech stocks have consistently been one of the best-performing groups of equities for almost 10 straight years. Vertex just might be the best biotech stock on the market right now. The company's three approved drugs -- Kalydeco, Orkambi, and Symdeko -- enjoy a virtual monopoly in treating the underlying Biotech Stocks to Buy: Voyager Therapeutics (VYGR) Voyager Therapeutics (NASDAQ: VYGR) shares are getting a lift off of their 50-week moving average ahead of a possible run to the highs not seen since March, which would be worth a 50%+ gain from here as it emerges from a two-month consolidation range. When it comes to mining, investors look for “safe havens” to hedge against financial crises. As for biotechnology, investors turn toward this area of the market as it tends to see less impact from geopolitical events. Here’s a list of 5 penny stocks to watch right now. Penny Stocks To Watch: Biocept Inc. Biotech stocks are off to a hot start in 2019, and these five stocks, in particular, could be the next winners. It’s debatable whether the stock market, as a whole, had a bear market or just a stiff correction to end 2018. There is, however, no such question about biotech stocks. The sector got clobbered last fall.

Sep 3, 2019 Right now, PharmaCyte Biotech (PMCB) is putting together the necessary material for its planned clinical trial for inoperable pancreatic cancer,  Jan 3, 2020 there is a huge demand for quality penny stocks in the market. It is often noted that investors end up making money when they invest in the right stocks. Cohen's fund has acquired a 9.8% stake in the biotech stock with a